J. David Hansen

2016

In 2016, J. David Hansen earned a total compensation of $975.6K as President, Chief Executive Officer and Chairman at MabVax Therapeutics Holdings, a 77% decrease compared to previous year.

Compensation breakdown

Bonus$141,400
Option Awards$393,702
Salary$404,746
Other$35,717
Total$975,565

Hansen received $404.7K in salary, accounting for 41% of the total pay in 2016.

Hansen also received $141.4K in bonus, $393.7K in option awards and $35.7K in other compensation.

Rankings

In 2016, J. David Hansen's compensation ranked 8,368th out of 14,075 executives tracked by ExecPay. In other words, Hansen earned more than 40.5% of executives.

ClassificationRankingPercentile
All
8,368
out of 14,075
41st
Division
Manufacturing
3,205
out of 5,489
42nd
Major group
Chemicals And Allied Products
1,076
out of 1,895
43rd
Industry group
Drugs
840
out of 1,538
45th
Industry
Pharmaceutical Preparations
666
out of 1,176
43rd
Source: SEC filing on May 2, 2017.

Hansen's colleagues

We found three more compensation records of executives who worked with J. David Hansen at MabVax Therapeutics Holdings in 2016.

2016

Paul Resnick

MabVax Therapeutics Holdings

Vice President, Chief Business Officer

2016

Paul Maffuid

MabVax Therapeutics Holdings

Vice President, Pharmaceutical Development and Operations

2016

Gregory Hanson

MabVax Therapeutics Holdings

Chief Financial Officer

You may also like